HomeInsightsMarket Capitalization

Market Capitalization of Aarti Pharmalabs Ltd

Market Capitalization of Aarti Pharmalabs Ltd

stocks purchased

₹ 0.4 Cr

Volume transacted

stocks purchased

6.7 K

stocks traded

Last Updated time: 10 Oct 15:30 PM

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

MARKETCAP

5613.83 crore

Last updated: 09 Oct 24

Key Highlights

  • The Market Cap of Aarti Pharmalabs Ltd is ₹ 5613 crore as of 09 Oct 24.
  • The Market Cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore on March 2021 to ₹ 3942 crore on March 2024 . This represents a CAGR of 25.85% over 2 years. .
  • The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 610.05 as of 10 Oct 15:30.

Historical Market Cap of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Company Fundamentals for Aarti Pharmalabs Ltd

No data available

Image

Aarti Pharmalabs Ltd

NSE: AARTIPHARMA

PRICE

610.05

-9.40 (-1.52%)

stock direction

Last updated: 10 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Aarti Pharmalabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 2024610.05
09 Oct 2024619.45
08 Oct 2024603.4
07 Oct 2024590.65
04 Oct 2024619.95
03 Oct 2024615.9
01 Oct 2024624.7
30 Sep 2024636.95
27 Sep 2024616.45
26 Sep 2024612.6

SWOT Analysis Of Aarti Pharmalabs Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aarti Pharmalabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aarti Pharmalabs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Aarti Pharmalabs Ltd

No data available

Historical P/E Ratio of Aarti Pharmalabs Ltd

No data available

* All values are in %

Historical Revenue of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical EBITDA of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Pharmalabs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Aarti Pharmalabs Ltd

No data available

* All values are in %

About Aarti Pharmalabs Ltd

  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019.
  • The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.
  • It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021.

Aarti Pharmalabs Ltd News Hub

News

Aarti Pharmalabs to convene board meeting

Aarti Pharmalabs will hold a meeting of the Board of Directors of the Company on 5 August ...

Read more

30 Jul 202411:17

News

Aarti Pharmalabs schedules AGM

Aarti Pharmalabs announced that the 91th Annual General Meeting (AGM) of the company will ...

Read more

17 Jul 202409:30

News

CRISIL reaffirms ratings of Aarti Pharmalabs with 'positive' outlook

CRISIL stated that the ratings continue to reflect the established market position in the ...

Read more

27 Jun 202413:54

News

Aarti Pharmalabs Ltd leads losers in 'A' group

Colgate-Palmolive (India) Ltd, Jyothy Labs Ltd, Archean Chemical Industries Ltd and Aarti ...

Read more

15 May 202415:00

News

Aarti Pharmalabs jumps after Q4 PAT climbs 52% YoY to Rs 65 cr

Revenue from operations increased 4.27% YoY to Rs 505.77 crore in Q4 FY24. Profit before t...

Read more

14 May 202409:43

News

Board of Aarti Pharmalabs recommends Final Dividend

Aarti Pharmalabs announced that the Board of Directors of the Company at its meeting held ...

Read more

13 May 202417:30

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Aarti Pharmalabs Ltd

What is the market cap of Aarti Pharmalabs Ltd?

As of October 10, 2024, Aarti Pharmalabs Ltd has a market capitalization of ₹5613.83, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Aarti Pharmalabs Ltd's market capitalization?

Aarti Pharmalabs Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Aarti Pharmalabs Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Aarti Pharmalabs Ltd's market capitalization change?

Aarti Pharmalabs Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*